Finally, we assessed METTL3 expression and its association with the prognosis of the 84 NSCLC patients, revealing that a high METTL3 expression level is correlated with poor overall survival (OS) (Fig. 1H). Here, METTL3 is linked to non-small cell lung carcinoma.